Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic HBV Vaccine (εPA-44) + Entecavir in Chronic Hepatitis B
NCT01326546Phase 2Completed
- Sponsor
- Chongqing Jiachen Biotechnology Ltd.
- Start
- Jun 2010
- Primary completion
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic HBV vaccine in Chronic Hepatitis B (CHB), sponsored by Chongqing Jiachen Biotechnology Ltd.. Started Jun 2010; status: completed.
02
Drugs
therapeutic HBV vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01326546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326546.